| DNA methylation-based classification of central nervous system tumours D Capper, DTW Jones, M Sill, V Hovestadt, D Schrimpf, D Sturm, ... Nature 555 (7697), 469-474, 2018 | 2618 | 2018 |
| The landscape of genomic alterations across childhood cancers SN Gröbner, BC Worst, J Weischenfeldt, I Buchhalter, K Kleinheinz, ... Nature 555 (7696), 321-327, 2018 | 1493 | 2018 |
| The whole-genome landscape of medulloblastoma subtypes PA Northcott, I Buchhalter, AS Morrissy, V Hovestadt, J Weischenfeldt, ... Nature 547 (7663), 311-317, 2017 | 1076 | 2017 |
| DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis F Sahm, D Schrimpf, D Stichel, DTW Jones, T Hielscher, S Schefzyk, ... The lancet oncology 18 (5), 682-694, 2017 | 814 | 2017 |
| Atypical teratoid/rhabdoid tumors are comprised of three epigenetic subgroups with distinct enhancer landscapes PD Johann, S Erkek, M Zapatka, K Kerl, I Buchhalter, V Hovestadt, ... Cancer cell 29 (3), 379-393, 2016 | 558 | 2016 |
| Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX M Ko, J An, HS Bandukwala, L Chavez, T Äijö, WA Pastor, MF Segal, H Li, ... Nature 497 (7447), 122-126, 2013 | 458 | 2013 |
| Active medulloblastoma enhancers reveal subgroup-specific cellular origins CY Lin, S Erkek, Y Tong, L Yin, AJ Federation, M Zapatka, P Haldipur, ... Nature 530 (7588), 57-62, 2016 | 425 | 2016 |
| PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin … P Borchmann, H Goergen, C Kobe, A Lohri, R Greil, DA Eichenauer, ... The Lancet 390 (10114), 2790-2802, 2017 | 407 | 2017 |
| Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort SM Waszak, PA Northcott, I Buchhalter, GW Robinson, C Sutter, ... The Lancet Oncology 19 (6), 785-798, 2018 | 396 | 2018 |
| MEDIPS: genome-wide differential coverage analysis of sequencing data derived from DNA enrichment experiments M Lienhard, C Grimm, M Morkel, R Herwig, L Chavez Bioinformatics 30 (2), 284-286, 2014 | 349 | 2014 |
| Large conserved domains of low DNA methylation maintained by Dnmt3a M Jeong, D Sun, M Luo, Y Huang, GA Challen, B Rodriguez, X Zhang, ... Nature genetics 46 (1), 17-23, 2014 | 343 | 2014 |
| Distinct roles of the methylcytosine oxidases Tet1 and Tet2 in mouse embryonic stem cells Y Huang, L Chavez, X Chang, X Wang, WA Pastor, J Kang, ... Proceedings of the National Academy of Sciences 111 (4), 1361-1366, 2014 | 309 | 2014 |
| Innate-like functions of natural killer T cell subsets result from highly divergent gene programs I Engel, G Seumois, L Chavez, D Samaniego-Castruita, B White, ... Nature immunology 17 (6), 728-739, 2016 | 308 | 2016 |
| Dynamic changes in chromatin accessibility occur in CD8+ T cells responding to viral infection JP Scott-Browne, IF López-Moyado, S Trifari, V Wong, L Chavez, A Rao, ... Immunity 45 (6), 1327-1340, 2016 | 306 | 2016 |
| Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes T Sharma, EC Schwalbe, D Williamson, M Sill, V Hovestadt, M Mynarek, ... Acta neuropathologica 138, 309-326, 2019 | 277 | 2019 |
| Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas KW Pajtler, J Wen, M Sill, T Lin, W Orisme, B Tang, JM Hübner, ... Acta neuropathologica 136, 211-226, 2018 | 255 | 2018 |
| Targeting glioblastoma stem cells through disruption of the circadian clock Z Dong, G Zhang, M Qu, RC Gimple, Q Wu, Z Qiu, BC Prager, X Wang, ... Cancer discovery 9 (11), 1556-1573, 2019 | 239 | 2019 |
| Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic … JT Huse, M Snuderl, DTW Jones, CD Brathwaite, N Altman, E Lavi, ... Acta neuropathologica 133, 417-429, 2017 | 232 | 2017 |
| Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome P Panwalkar, J Clark, V Ramaswamy, D Hawes, F Yang, C Dunham, ... Acta neuropathologica 134, 705-714, 2017 | 223 | 2017 |
| Epigenomic analysis of primary human T cells reveals enhancers associated with TH2 memory cell differentiation and asthma susceptibility G Seumois, L Chavez, A Gerasimova, M Lienhard, N Omran, L Kalinke, ... Nature immunology 15 (8), 777-788, 2014 | 216 | 2014 |
Stefan M. PfisterProfessor of Pediatrics, Hopp-Children´s Cancer Center Heidelberg (KiTZ)Email verificata su kitz-heidelberg.de
